RT - Journal Article T1 - Evaluation of pomegranate rind (Punica granatum) hydroethanolic extract on blood parameters in male mice treated by Irinotecan Hcl JF - yums-armaghan YR - 2015 JO - yums-armaghan VO - 20 IS - 2 UR - http://armaghanj.yums.ac.ir/article-1-487-en.html SP - 114 EP - 126 K1 - Anemia K1 - Irinotecan Hcl K1 - Mice K1 - Pomegranate rind extrac. AB - Background & aim: Irinotecan Hcl is the first order drug for some neoplasm treatment in patients. Irinotecan Hcl has side effects on blood such as anemia and leukopeny. The aim of this study was to evaluate erythropoetic effects of the pomegranate hydroethanolic extract were examined on mice which treated by irinotecan Hcl. Methods: In this experimental study, 49 male mice (25-30 g) were divided in 7 groups (control, sham, treated by irinotecan Hcl (100 mg/kg), treated by pomegranate extract (100 and 400 mg/kg, i.p, daily for one week) and treated by irinotecan Hcl plus pomegranate extract (100 and 400 mg/kg, i.p, daily for one week) randomly. Anemia induced by administration of irinotecan in the experimental animal. At the end of experiment the blood samples were collected by cardiac puncture method and analized for RBC, WBC, Hb, Hct parameters. Data were analyzed using one-way ANOVA and Tukey’s test. Results: The results of this study showed that irinotecan has affected on blood factors and cause to significance decrese compared with control group (p LA eng UL http://armaghanj.yums.ac.ir/article-1-487-en.html M3 ER -